PTENP1 and cancer: Manipulating PTEN, microRNA, and PTENP1 levels through therapeutic targeting represents a new frontier in cancer treatment, suggesting the potential to treat various cancer types if precise therapeutic targeting successfully surpasses the first phase of clinical trials in humans.